Upsurge Seeds (USASEEDS)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/E of 13.73 is not demanding for a profitable small-cap business
• Latest quarter shows positive absolute profit: ₹3 Cr net profit on ₹47 Cr sales
• ROCE of 12.98% indicates decent capital efficiency
• Promoter holding of 71.15% aligns promoter interests with minority shareholders

Concerns

• Sales declining by 7.74% and profit declining by 1.93% show weak momentum
• Piotroski F-Score of 3/9 points to weak financial health and operational stress
• No dividend yield, so shareholders depend entirely on uncertain business performance
• Share price collapsed from ₹314.40 to ₹104, reflecting severe loss of investor confidence

AI Analysis

At ₹104, Upsurge Seeds is a small-cap agri-seed business with a market cap of ₹116 Cr. On the surface, the P/E of 13.73 looks cheap, but I have learned that cheap can become cheaper if the business is deteriorating. Sales declined by 7.74% and profit by 1.93%. The latest quarter shows ₹47 Cr in sales and ₹3 Cr in net profit, implying a thin margin of roughly 6.4%. ROCE of 12.98% is respectable, but with negative growth, I cannot call this a compounding machine. The Piotroski F-Score of 3/9 is a serious red flag; it suggests weak operational fundamentals, poor financial health, and limited margin of safety. I also cannot complete my analysis without book value, ROE, or debt-equity data. No dividend means the only return comes from business performance, and right now that performance is shrinking. The stock has fallen from ₹314.40 to ₹104 — a decline of about 67% — which tells me the market has already lost patience. Promoter holding at 71.15% is encouraging; the owners have skin in the game. But high ownership alone does not create a moat. In the seed business, repeat purchases and distribution matter. I need to know whether this decline is cyclical or structural. With sales and profits both falling and a weak F-score, this looks like a turnaround candidate, not a proven one. I would wait for evidence of stabilisation before investing. As Ben Graham said, price is what you pay, value is what you get. At ₹104, the market is pricing in trouble. I want proof of recovery, not hope.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer